Zelix Pharmaceuticals Files BLA for PET Imaging Agent for Renal Cell Carcinoma

Trial data show 89Zr-DFO-girentuximab was more effective than traditional PET/CT imaging in identifying malignant renal cell carcinoma lesions.

Source link
#Zelix #Pharmaceuticals #Files #BLA #PET #Imaging #Agent #Renal #Cell #Carcinoma